Temporary importation of Iomeron® (iomeprol injection) to address drug shortage issues
Due to a prior shortage of iodinated contrast media indicated for intravascular use in the U.S. market, Bracco Diagnostics Inc. (hereafter "Bracco"), coordinated with the U.S. Food and Drug Administration (FDA) to help increase its availability.